Amplified release through the stimulus triggered degradation of self-immolative oligomers, dendrimers, and linear polymers.
暂无分享,去创建一个
[1] J. Chern,et al. Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy. , 2008, Journal of medicinal chemistry.
[2] Richard A Lerner,et al. Prodrug activation gated by a molecular "OR" logic trigger. , 2005, Angewandte Chemie.
[3] P. Trail,et al. (6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin. , 1993, Bioconjugate chemistry.
[4] H. W. Scheeren,et al. Plasmin‐activated doxorubicin prodrugs containing a spacer reduce tumor growth and angiogenesis without systemic toxicity , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] A. Romieu,et al. Chemiluminescent probe for the in vitro detection of protease activity. , 2007, Organic letters.
[6] P. Ferruti,et al. New poly(amidoamine)s containing disulfide linkages in their main chain , 2005 .
[7] F. Szoka,et al. A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas , 2006, Proceedings of the National Academy of Sciences.
[8] D. Thompson,et al. Comparative toxicity of eugenol and its quinone methide metabolite in cultured liver cells using kinetic fluorescence bioassays. , 1998, Toxicology and applied pharmacology.
[9] Roey J. Amir,et al. Receiver-amplifier, self-immolative dendritic device. , 2007, Chemistry.
[10] W. Denny. Hypoxia-activated prodrugs in cancer therapy: progress to the clinic. , 2010, Future oncology.
[11] J. West,et al. Thermo-responsive systems for controlled drug delivery. , 2008, Expert opinion on drug delivery.
[12] Istvan J. Majoros,et al. Dendrimer-Based Nanomedicine , 2008 .
[13] C. Monneret,et al. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy. , 2006, Bioorganic & medicinal chemistry.
[14] D. Shabat,et al. Molecular probe for enzymatic activity with dual output. , 2007, Bioorganic & medicinal chemistry.
[15] B. Jo,et al. Polymer prodrug approaches applied to paclitaxel , 2010 .
[16] Xiaobing Zhang,et al. An autoimmolative spacer allows first-time incorporation of a unique solid-state fluorophore into a detection probe for acyl hydrolases. , 2010, Chemistry.
[17] D. McGrath,et al. Phototriggering of geometric dendrimer disassembly: An improved synthesis of 2,4-bis(hydroxymethyl)phenol based dendrimers , 2004 .
[18] H. Kroemer,et al. Elucidation of the mechanism enabling tumor selective prodrug monotherapy. , 1998, Cancer research.
[19] S. Smith,et al. Cyclization-activated prodrugs. Basic carbamates of 4-hydroxyanisole. , 1990, Journal of medicinal chemistry.
[20] Ruixue Liu,et al. Thermoresponsive copolymers: from fundamental studies to applications , 2009 .
[21] A. Wahl,et al. Protease-mediated fragmentation of p-amidobenzyl ethers: a new strategy for the activation of anticancer prodrugs. , 2002, The Journal of organic chemistry.
[22] Jean M. J. Fréchet,et al. Synthesis and Degradation of pH-Sensitive Linear Poly(amidoamine)s , 2007 .
[23] Xianrui Zhao,et al. Mechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release. , 2010, Bioconjugate chemistry.
[24] Samir Mitragotri,et al. Designer Biomaterials for Nanomedicine , 2009 .
[25] J. Geffner,et al. Extracellular acidification induces human neutrophil activation. , 1999, Journal of immunology.
[26] C. H. Laycock. The Receiver/Amplifier , 1976 .
[27] D. Shabat,et al. Enzymatic activation of hydrophobic self-immolative dendrimers: the effect of reporters with ionizable functional groups. , 2009, Bioorganic & medicinal chemistry letters.
[28] L. Murray,et al. Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[29] D. Kroll,et al. Design, synthesis, and biological evaluation of antibody-drug conjugates comprised of potent camptothecin analogues. , 2009, Bioconjugate chemistry.
[30] D. Shabat,et al. Self-immolative polymers. , 2008, Journal of the American Chemical Society.
[31] Roey J. Amir,et al. Self-immolative dendrimer biodegradability by multi-enzymatic triggering. , 2004, Chemical communications.
[32] C. Monneret,et al. Synthesis of self-immolative glucuronide spacers based on aminomethylcarbamate. Application to 5-fluorouracil prodrugs for antibody-directed enzyme prodrug therapy , 1999 .
[33] A. Romieu,et al. A HTS assay for the detection of organophosphorus nerve agent scavengers. , 2010, Chemistry.
[34] F. Friedlos,et al. Self-immolative prodrugs: candidates for antibody-directed enzyme prodrug therapy in conjunction with a nitroreductase enzyme. , 1994, Journal of medicinal chemistry.
[35] D. Kerr,et al. Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] Influence of the linker on the biodistribution and catabolism of actinium-225 self-immolative tumor-targeted isotope generators. , 2006, Bioconjugate chemistry.
[37] R. Satchi‐Fainaro,et al. Remarkable drug-release enhancement with an elimination-based AB3 self-immolative dendritic amplifier. , 2007, Bioorganic & medicinal chemistry.
[38] J. P. Irigoyena,et al. The plasminogen activator system : biology and regulation , 2022 .
[39] H. Lode,et al. Bioactivation of self-immolative dendritic prodrugs by catalytic antibody 38C2. , 2004, Journal of the American Chemical Society.
[40] C. Allen,et al. Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[41] Roey J. Amir,et al. Substituent-dependent disassembly of self-immolative dendrimers , 2007 .
[42] R. Borchardt,et al. Prodrug strategies based on intramolecular cyclization reactions. , 1997, Journal of pharmaceutical sciences.
[43] D. Leeper,et al. Extracellular pH distribution in human tumours. , 1995, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[44] N. Murthy,et al. A novel strategy for encapsulation and release of proteins: hydrogels and microgels with acid-labile acetal cross-linkers. , 2002, Journal of the American Chemical Society.
[45] Jim Euchner. Design , 2014, Catalysis from A to Z.
[46] M. Wakselman. THE 1,4 AND 1,6 ELIMINATIONS FROM HYDROXY‐ AND AMINO‐SUBSTITUTED BENZYL SYSTEMS: CHEMICAL AND BIOCHEMICAL APPLICATIONS , 1983 .
[47] E. Gillies,et al. Design, synthesis, and cyclization of 4-aminobutyric acid derivatives: potential candidates as self-immolative spacers. , 2011, Organic & biomolecular chemistry.
[48] P. Baran,et al. The pyridinone-methide elimination. , 2009, Organic & biomolecular chemistry.
[49] Elizabeth R Gillies,et al. A cascade biodegradable polymer based on alternating cyclization and elimination reactions. , 2009, Journal of the American Chemical Society.
[50] J. Klafter,et al. Two-component dendritic chain reactions: experiment and theory. , 2010, Journal of the American Chemical Society.
[51] F. Kratz,et al. Development of dual-acting prodrugs for circumventing multidrug resistance. , 2009, Bioorganic & medicinal chemistry letters.
[52] Prodrug Strategies in Anticancer Chemotherapy , 2008, ChemMedChem.
[53] Jean M. J. Fréchet,et al. Dendrimers and other dendritic polymers , 2001 .
[54] Simon A. Williams,et al. Modulating paclitaxel bioavailability for targeting prostate cancer. , 2007, Bioorganic & medicinal chemistry.
[55] P. Senter. Activation of prodrugs by antibody‐enzyme conjugates: a new approach to cancer therapy , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[56] Jean M. J. Fréchet,et al. Development of acid-sensitive copolymer micelles for drug delivery , 2004 .
[57] L. Tietze,et al. Duocarmycin-based prodrugs for cancer prodrug monotherapy. , 2008, Bioorganic & medicinal chemistry.
[58] Phil S Baran,et al. Activity-linked labeling of enzymes by self-immolative polymers. , 2009, Bioconjugate chemistry.
[59] Dendritic chain reaction: responsive release of hydrogen peroxide upon generation and enzymatic oxidation of methanol. , 2010, Bioorganic & medicinal chemistry.
[60] L. Tietze,et al. Synthesis of the first spacer containing prodrug of a duocarmycin analogue and determination of its biological activity. , 2010, Organic & biomolecular chemistry.
[61] D. Shabat,et al. Self-immolative comb-polymers: multiple-release of side-reporters by a single stimulus event. , 2008, Chemistry.
[62] R. Satchi‐Fainaro,et al. Real-time monitoring of drug release. , 2010, Chemical communications.
[63] C. Monneret,et al. Protecting groups for glucuronic acid: application to the synthesis of new paclitaxel (taxol) derivatives. , 2006, The Journal of organic chemistry.
[64] Sudesh Kumar Yadav,et al. Biodegradable polymeric nanoparticles based drug delivery systems. , 2010, Colloids and surfaces. B, Biointerfaces.
[65] Soong-Hoon Kim,et al. Regioselective synthesis of folate receptor-targeted agents derived from epothilone analogs and folic acid. , 2010, Bioorganic & medicinal chemistry letters.
[66] A. Satyam. Design and synthesis of releasable folate-drug conjugates using a novel heterobifunctional disulfide-containing linker. , 2008, Bioorganic & medicinal chemistry letters.
[67] R. Satchi‐Fainaro,et al. Enhanced cytotoxicity of a polymer-drug conjugate with triple payload of paclitaxel. , 2009, Bioorganic & medicinal chemistry.
[68] G. Dubowchik,et al. Cathepsin B-sensitive dipeptide prodrugs. 1. A model study of structural requirements for efficient release of doxorubicin. , 1998, Bioorganic & medicinal chemistry letters.
[69] R. Weissleder,et al. A self-immolative reporter for beta-galactosidase sensing. , 2007, Chembiochem : a European journal of chemical biology.
[70] J. Katzenellenbogen,et al. A novel connector linkage applicable in prodrug design. , 1981, Journal of medicinal chemistry.
[71] L. Gerweck,et al. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. , 1996, Cancer research.
[72] Zhiyuan Zhong,et al. Stimuli-responsive polymersomes for programmed drug delivery. , 2009, Biomacromolecules.
[73] Roey J. Amir,et al. Self-immolative dendrimers. , 2003, Angewandte Chemie.
[74] D. Kerr,et al. Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. , 2009, International journal of oncology.
[75] P. Baran,et al. Sulfhydryl-based dendritic chain reaction. , 2010, Chemical communications.
[76] Dennis E Discher,et al. Polymersome carriers: from self-assembly to siRNA and protein therapeutics. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[77] H. W. Scheeren,et al. Novel anthracycline-spacer-beta-glucuronide,-beta-glucoside, and -beta-galactoside prodrugs for application in selective chemotherapy. , 1999, Bioorganic & medicinal chemistry.
[78] C. Monneret,et al. Glucuronide prodrugs of hydroxy compounds for antibody directed enzyme prodrug therapy (ADEPT) : A phenol nitrogen mustard carbamate , 1997 .
[79] A. Romieu,et al. Development of a new nonpeptidic self-immolative spacer. Application to the design of protease sensing fluorogenic probes. , 2008, Organic letters.
[80] J. Fréchet,et al. pH-Responsive copolymer assemblies for controlled release of doxorubicin. , 2005, Bioconjugate chemistry.
[81] S. Kawakami,et al. Designing Dendrimers for Drug Delivery and Imaging: Pharmacokinetic Considerations , 2011, Pharmaceutical Research.
[82] J. Knipe,et al. Cathepsin B-sensitive dipeptide prodrugs. 2. Models of anticancer drugs paclitaxel (Taxol), mitomycin C and doxorubicin. , 1998, Bioorganic & medicinal chemistry letters.
[83] James B. Mitchell,et al. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. , 2002, Cancer research.
[84] K. Kataoka,et al. Glutathione-sensitive stabilization of block copolymer micelles composed of antisense DNA and thiolated poly(ethylene glycol)-block-poly(L-lysine): a potential carrier for systemic delivery of antisense DNA. , 2001, Biomacromolecules.
[85] Scott R White,et al. Programmable microcapsules from self-immolative polymers. , 2010, Journal of the American Chemical Society.
[86] R. Müller,et al. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes. , 2010, Handbook of experimental pharmacology.
[87] R. Lerner,et al. Single-triggered trimeric prodrugs. , 2005, Angewandte Chemie.
[88] D. Shabat,et al. Self-immolative dendritic probe for direct detection of triacetone triperoxide. , 2008, Chemical communications.
[89] Francis C Szoka,et al. Designing dendrimers for biological applications , 2005, Nature Biotechnology.
[90] Fenghua Meng,et al. Biodegradable polymersomes as a basis for artificial cells: encapsulation, release and targeting. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[91] I Mellman,et al. Acidification of the endocytic and exocytic pathways. , 1986, Annual review of biochemistry.
[92] D. McGrath,et al. Geometric disassembly of dendrimers: dendritic amplification. , 2003, Journal of the American Chemical Society.
[93] H. W. Scheeren,et al. "Cascade-release dendrimers" liberate all end groups upon a single triggering event in the dendritic core. , 2003, Angewandte Chemie.
[94] D. McGrath,et al. Dendrimer disassembly by benzyl ether depolymerization. , 2003, Journal of the American Chemical Society.
[95] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[96] H. W. Scheeren,et al. Elongated multiple electronic cascade and cyclization spacer systems in activatible anticancer prodrugs for enhanced drug release. , 2001, The Journal of organic chemistry.
[97] W. Hennink,et al. Reduction-sensitive polymers and bioconjugates for biomedical applications. , 2009, Biomaterials.
[98] J. Feijen,et al. Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery. , 2006, Bioconjugate chemistry.
[99] Atsushi Harada,et al. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. , 2003, Angewandte Chemie.
[100] D. McGrath,et al. Convergent synthesis of geometrically disassembling dendrimers using Cu(I)-catalyzed C-O bond formation. , 2010, Organic letters.
[101] W. Tan,et al. A highly selective ratiometric fluorescent probe for 1,4-dithiothreitol (DTT) detection. , 2010, Organic & biomolecular chemistry.
[102] María J Vicent,et al. Polymer therapeutics: clinical applications and challenges for development. , 2009, Advanced drug delivery reviews.
[103] E. Gillies,et al. A reduction sensitive cascade biodegradable linear polymer , 2010 .
[104] Raphael Dumeunier,et al. Latent fluorophores based on a self-immolative linker strategy and suitable for protease sensing. , 2008, Bioconjugate chemistry.
[105] H. Haisma,et al. Synthesis and evaluation of [18F]-FEAnGA as a PET Tracer for beta-glucuronidase activity. , 2010, Bioconjugate chemistry.
[106] M. Thomas,et al. Design of self-immolative linkers for tumour-activated prodrug therapy. , 2008, Anti-cancer agents in medicinal chemistry.
[107] F. Kratz,et al. 2,4-Bis(hydroxymethyl)aniline as a building block for oligomers with self-eliminating and multiple release properties. , 2008, The Journal of organic chemistry.
[108] J. B. Christensen,et al. Dendrimers in medicine and biotechnology. New molecular tools , 2006 .
[109] C. Conover,et al. Poly(ethylene glycol) conjugated drugs and prodrugs: a comprehensive review. , 2000, Critical reviews in therapeutic drug carrier systems.
[110] D. Shabat,et al. Single-triggered AB6 self-immolative dendritic amplifiers. , 2007, Chemistry.
[111] Yuichi Yamasaki,et al. PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors. , 2008, Journal of the American Chemical Society.
[112] A. Romieu,et al. A comparative study of the self-immolation of para-aminobenzylalcohol and hemithioaminal-based linkers in the context of protease-sensitive fluorogenic probes. , 2010, Organic & biomolecular chemistry.
[113] J. Fréchet,et al. Dendrimers and dendritic polymers in drug delivery. , 2005, Drug discovery today.
[114] P. Senter,et al. Development of a drug-release strategy based on the reductive fragmentation of benzyl carbamate disulfides , 1990 .
[115] Marc Dellian,et al. Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[116] H. Zhao,et al. Drug delivery systems employing 1,4- or 1,6-elimination: poly(ethylene glycol) prodrugs of amine-containing compounds. , 1999, Journal of medicinal chemistry.
[117] R. Weissleder,et al. A Self‐Immolative Reporter For β‐Galactosidase Sensing , 2007 .
[118] P. M. Deckert,et al. Targeted enzyme prodrug therapies. , 2010, Mini reviews in medicinal chemistry.
[119] Ruth Duncan,et al. Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.
[120] T. Monks,et al. The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers. , 2002, Current drug metabolism.
[121] N. Murthy,et al. Polyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle. , 2005, Bioconjugate chemistry.
[122] Joel A Swanson,et al. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. , 2003, Advanced drug delivery reviews.
[123] D. Shabat,et al. Dendritic chain reaction. , 2009, Journal of the American Chemical Society.
[124] Adah Almutairi,et al. UV and near-IR triggered release from polymeric nanoparticles. , 2010, Journal of the American Chemical Society.
[125] K. Ulbrich,et al. HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[126] B. Attali,et al. Enzymatic activation of second-generation dendritic prodrugs: Conjugation of self-immolative dendrimers with poly(ethylene glycol) via click chemistry. , 2006, Bioconjugate chemistry.
[127] F. Kratz,et al. Prodrugs of anthracyclines in cancer chemotherapy. , 2006, Current medicinal chemistry.